Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|MS Research
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Member News
- MS Research
- Press Releases
- Stakeholder Events
- Young People with MS
More than 21,000 people call for action on ocrelizumab for Primary Progressive MS in the UK
More than 21,000 people have signed a petition launched by the MS Society UK, calling for ocrelizumab to be made…
21st State of Art Symposium around the challenges of MS treatment in Switzerland
Paediatric MS and MS in old age were the two main topics neurologists explored at the 21st State of the…
Restriction on second-line treatment lifted in Poland
By: Yves Brand Restriction on second-line treatment lifted in Poland Good news from Poland where this week the Polish government…